BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34673095)

  • 1. ICH Q3D Drug Product Elemental Risk Assessment: The Use of An Elemental Impurities Excipients Database.
    Torres S; Boetzel R; Gatimu E; Gomes DZ; King F; Kocks G; Jones R; Day C; Lewen N; Harris L; Teasdale A
    J Pharm Sci; 2022 May; 111(5):1421-1428. PubMed ID: 34673095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Elemental Impurities Excipient Database: A Viable Tool for ICH Q3D Drug Product Risk Assessment.
    Boetzel R; Ceszlak A; Day C; Drumm P; Gil Bejar J; Glennon J; Harris L; Heghes CI; Horga R; Jacobs PL; Keurentjes WJTM; King F; Lee CW; Lewen N; Marchant CA; Maris FA; Nye W; Powell S; Rockstroh H; Rutter L; Schweitzer M; Shannon E; Smallshaw L; Teasdale A; Thompson S; Wilkinson D
    J Pharm Sci; 2018 Sep; 107(9):2335-2340. PubMed ID: 29679706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of ICH-Q3D Elemental Impurity Leachables in Glass Vials by Inductively Coupled Plasma Mass Spectrometry.
    Breckenridge L; Oni Y; Evans C; Franck J; Wood S; Xu M; Sahin E; Zacour B
    PDA J Pharm Sci Technol; 2023; 77(3):197-210. PubMed ID: 36241213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Risk-Based Approach to Evaluate and Control Elemental Impurities in Therapeutic Proteins.
    Luo Y; Sekhar C; Lee H; Fujimori K; Ronk M; Semin D; Nashed-Samuel Y
    J Pharm Sci; 2020 Nov; 109(11):3378-3385. PubMed ID: 32745562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elemental Impurities in Pharmaceutical Excipients.
    Li G; Schoneker D; Ulman KL; Sturm JJ; Thackery LM; Kauffman JF
    J Pharm Sci; 2015 Dec; 104(12):4197-4206. PubMed ID: 26398581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Extractable Elements from Elastomers.
    Paskiet D; Kraft C; Tullo E; Hunter J; Zurbriggen D
    PDA J Pharm Sci Technol; 2019; 73(1):83-91. PubMed ID: 30030347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of X-ray fluorescence spectrometry for screening pharmaceutical products for Elemental Impurities according to ICH guideline Q3D.
    Sauer B; Xiao Y; Zoontjes M; Kroll C
    J Pharm Biomed Anal; 2020 Feb; 179():113005. PubMed ID: 31812806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How One Might Experimentally Determine if Container Closure Systems and Their Components and Materials of Construction Contribute Elemental Impurities To Packaged Pharmaceutical Drug Products.
    Jenke D
    PDA J Pharm Sci Technol; 2019; 73(2):181-190. PubMed ID: 30232139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A direct LA-ICP-MS screening of elemental impurities in pharmaceutical products in compliance with USP and ICH-Q3D.
    Pluháček T; Ručka M; Maier V
    Anal Chim Acta; 2019 Oct; 1078():1-7. PubMed ID: 31358206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility.
    Wu Y; Levons J; Narang AS; Raghavan K; Rao VM
    AAPS PharmSciTech; 2011 Dec; 12(4):1248-63. PubMed ID: 21948318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICH Q3D based elemental impurities study in liquid pharmaceutical dosage form with high daily intake - comparative analysis by ICP-OES and ICP-MS.
    Janchevska K; Stafilov T; Memed-Sejfulah S; Bogdanoska M; Ugarkovic S; Petrushevski G
    Drug Dev Ind Pharm; 2020 Mar; 46(3):456-461. PubMed ID: 31999195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the compatibility of oral magnesium oxide preparations sold in Japan with the ICH-Q3D guideline for elemental impurities.
    Satoh M; Motokawa K; Uesawa Y; Ishikawa Y; Maeda H; Iida K; Tanaka H; Kosugi T; Nishizawa K
    Drug Discov Ther; 2021 Nov; 15(5):227-235. PubMed ID: 34719603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Level of Cadmium Impurities in Traditional Herbal Medicinal Products with Plantago lanceolata L., folium (Ribwort Plantain Leaves) Available in Polish Pharmacies - Comprehensive Toxicological Risk Assessment Including Regulatory Point of View and ICH Q3D Elemental Impurities Guideline.
    Jurowski K; Fołta M; Tatar B; Krośniak M
    Biol Trace Elem Res; 2022 Jun; 200(6):2963-2969. PubMed ID: 34373979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elemental impurities in pharmaceutical products adding fuel to the fire.
    Maithani M; Raturi R; Sharma P; Gupta V; Bansal P
    Regul Toxicol Pharmacol; 2019 Nov; 108():104435. PubMed ID: 31376414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Nitrite Excipient Database: A Useful Tool to Support N-Nitrosamine Risk Assessments for Drug Products.
    Boetzel R; Schlingemann J; Hickert S; Korn C; Kocks G; Luck B; Blom G; Harrison M; François M; Allain L; Wu Y; Bousraf Y
    J Pharm Sci; 2023 Jun; 112(6):1615-1624. PubMed ID: 35500671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the use of axial viewed inductively coupled plasma atomic emission spectrometry with ultrasonic nebulization for the determination of select elemental impurities in oral drug products.
    Menoutis J; Parisi A; Verma N
    J Pharm Biomed Anal; 2018 Apr; 152():12-16. PubMed ID: 29414002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid screening of pharmaceutical products for elemental impurities by a high-resolution portable energy dispersive X-ray fluorescence spectrometer using an efficient fundamental parameter method.
    Zhu L; Teng Y; Han W; Yin L; Teng X
    Analyst; 2023 Feb; 148(5):1116-1122. PubMed ID: 36723086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Materials in Manufacturing and Packaging Systems as Sources of Elemental Impurities in Packaged Drug Products: An Updated Literature Review.
    Jenke D
    PDA J Pharm Sci Technol; 2020; 74(3):324-347. PubMed ID: 31843988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of pharmaceutical excipients with supercritical fluid extraction.
    Ashraf-Khorassani M; Taylor LT; Waterman KC; Narayan P; Brannegan DR; Reid GL
    Pharm Dev Technol; 2005; 10(4):507-16. PubMed ID: 16370180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP 〈232〉/〈233〉.
    Chahrour O; Malone J; Collins M; Salmon V; Greenan C; Bombardier A; Ma Z; Dunwoody N
    J Pharm Biomed Anal; 2017 Oct; 145():84-90. PubMed ID: 28654780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.